DRUG-RELEASING STENT HAVING EXTENSION(S) FOR TREATING LONG LESIONS

• US 20090036977A1
• Filed: 04/16/2008
• Published: 02/05/2009
• Est. Priority Date: 04/17/2007
• Status: Abandoned Application

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Inventors: Sutermeister, Derek, Petersen, Scott, Rassat, Jay
• Application Number:
  US12/103,750
• Publication Number:
  US 20090036977A1
• Time in Patent Office: Days
• US Class Current: 623/1.420
• CPC Class Codes: A61F 2/07 Stent-grafts
• CPC Class Codes: A61F 2/856 Single tubular stent with a side portal passage
• CPC Class Codes: A61F 2/89 the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
• CPC Class Codes: A61F 2/91 made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
• CPC Class Codes: A61F 2/915 with bands having a meander structure, adjacent bands being connected to each other
• CPC Class Codes: A61F 2002/828 Means for connecting a plurality of stents allowing flexibility of the whole structure
• CPC Class Codes: A61F 2002/91525 within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
• CPC Class Codes: A61F 2002/91541 Adjacent bands are arranged out of phase
• CPC Class Codes: A61F 2002/91575 connected peak to trough
• CPC Class Codes: A61F 2220/005 using adhesives
• CPC Class Codes: A61F 2220/0058 soldered or brazed or welded
• CPC Class Codes: A61F 2220/0075 sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
• CPC Class Codes: A61F 2250/0039 differing in diameter
• CPC Class Codes: A61F 2250/006 modular
• CPC Class Codes: A61F 2250/0067 Means for introducing or releasing pharmaceutical products into the body

Abstract

This invention generally relates to a system for treating body lumens, comprising stents, such as intravascular stents. More particularly, the invention is directed to stents having extensions attached on the ends thereof. The invention is also directed to methods for making and using such stents.

Claims

1. A system for treating a lumen comprising:

a first stent having a surface, a first end, a second end, and a coating composition comprising a first polymer and a first therapeutic agent disposed on the surface;

a first tubular extension attached to the second end of the first stent, wherein the first extension comprises a second polymer and a second therapeutic agent and

a second stent having a surface, a first end and a second end, wherein the first end of the second stent forms an overlap with the first extension.

2. The system of claim 1, wherein the first extension is disposed within the first end of the second stent.

3. The system of claim 1, wherein the first end of the second stent is disposed within the first extension.

4. The system of claim 1, wherein the first end of the second stent forms an overlap with less than the entire first extension.

5. The system of claim 1 wherein the first and second polymers are the same.

6. The system of claim 1, wherein the first and second therapeutic agents are the same.

7. The system of claim 1 wherein the surface of the first stent is an abluminal surface.

8. The system of claim 1 wherein the second stent further comprises the coating composition disposed on the surface of the second stent.

9. The system of claim 8 wherein the surface of the second stent is an abluminal surface.

10. The system of claim 1 wherein the first and second stents are intravascular stents.

11. The system of claim 1, wherein the first stent comprises a stent sidewall structure comprising a plurality of struts and a plurality of openings therein;

and wherein the coating composition conforms to the surface to preserve the openings.

12. The system of claim 1, wherein the first stent comprises a metal.

13. The system of claim 1, wherein the first extension has a thickness of about 5 μ

m to about 50 μ

m.

14. The system of claim 1 wherein the second stent further comprises a second tubular extension attached to the second end of the second stent, wherein the second extension comprises a third polymer and a third therapeutic agent.

15. The system of claim 14, wherein the third polymer is the same as the second polymer.

16. The system of claim 14, wherein the third therapeutic agent is the same as the second therapeutic agent.

17. The system of claim 14, further comprising a third stent having a first end and a second end, wherein the third stent forms an overlap with the second extension.

18. The system of claim 17, wherein the second extension is disposed within the first end of the third stent.

19. The system of claim 17, wherein the first end of the third stent is disposed within the second extension.

20. The system of claim 17, wherein the third stent forms an overlap with less than the entire second extension.

21. The system of claim 1 wherein the first stent further comprises a second tubular extension attached to the first end of the first stent, wherein the second extension comprises a third polymer and a third therapeutic agent.

22. The system of claim 21, wherein the third polymer is the same as the second polymer.

23. The system of claim 21, wherein the third therapeutic agent is the same as the second therapeutic agent.

24. The system of claim 21, further comprising a third stent having a first end and a second end, wherein the second end of the third stent forms an overlap with the second extension.

25. The system of claim 24, wherein the second extension is disposed within the second end of the third stent.

26. The system of claim 24, wherein the second end of the third stent is disposed within the second extension.

27. The system of claim 24, wherein the second end of the third stent forms an overlap with less than the entire second extension.

28. The system of claim 1, wherein the first therapeutic agent comprises paclitaxel or everolimus.

29. The system of claim 1, wherein the first polymer comprises PVDF.

30. The system of claim 1, wherein the second end of the first stent has a first diameter and the first end of the second stent has a second diameter, and wherein the first diameter is different from the second diameter.

31. The system of claim 30, wherein the first diameter is greater than the second diameter.

32. The system of claim 1, wherein the first extension comprises a first end having a first diameter and a second end comprising a second diameter;

wherein the first end of the first extension is attached to the second end of the first stent; and

wherein the first diameter is different from the second diameter prior to the first extension being attached to the second end of the first stent.

33. A system for treating a blood vessel comprising:

a first intravascular metal stent having a surface, a first end, a second end, and a coating composition comprising a first polymer and an agent for inhibiting the proliferation of smooth muscle cells disposed on the surface; and

a first tubular extension attached to the second end of the first stent, wherein the first extension comprises a second polymer and the agent for inhibiting the proliferation of smooth muscle cells; and

a second intravascular metal stent having a surface, the coating composition disposed on the surface of the second stent, a first end and a second end, wherein the first end of the second stent forms an overlap with less than the entire first extension.

34. A system for treating a blood vessel comprising:

a first intravascular metal stent having an abluminal surface, a first end, a second end, and a coating composition comprising a first biostable polymer and an anti-restenosis agent disposed on the abluminal surface; and

a first tubular extension attached to the second end, wherein the first extension comprises a second biostable polymer and the anti-restenosis agent and

a second intravascular metal stent having an abluminal surface, a first end and a second end, wherein the first end of the second stent forms an overlap with less than the entire first extension.

35. A system for treating a bifurcated lumen comprising:

a bifurcated stent comprising a surface, a first tubular portion, a second tubular portion, a third tubular portion having an end and a tubular extension attached to the end of the third tubular portion; and

a non-bifurcated stent comprising a surface, a first end and a second end, wherein the first end of the non-bifurcated stent forms an overlap the extension.

36. The system of claim 35, wherein the extension is disposed within the first end of the non-bifurcated stent.

37. The system of claim 35, wherein the first end of the non-bifurcated stent is disposed within the extension.

38. The system of claim 35, wherein the first end of the non-bifurcated stent forms an overlap with less than the entire extension.

39. The system of claim 35, wherein the extension comprises a first polymer

40. The system of claim 35, wherein the extension comprises a first therapeutic agent.

41. The system of claim 35 further comprising a graft disposed in contact with the bifurcated stent.

42. The system of claim 41 wherein the graft comprises a first polymer.

43. The system of claim 42 wherein the bifurcated stent further comprises a coating composition disposed on the surface of the bifurcated stent.

44. The system of claim 43 wherein the coating composition comprises a second polymer.

45. The system of claim 44 wherein the first and second polymers are the same.

46. The system of claim 43 wherein the coating composition comprises a therapeutic agent.

47. The system of claim 46 wherein the therapeutic agents comprise an anti-thrombogenic agent, anti-angiogenesis agent, anti-proliferative agent, antibiotic, anti-restenosis agent, growth factor, immunosuppressant, or radiochemical.

48. The system of claim 43 wherein the surface of the bifurcated stent is an abluminal surface.

49. The system of claim 35 wherein the non-bifurcated stent further comprises the coating composition disposed on the surface of the non-bifurcated stent.

50. The system of claim 43, wherein the bifurcated stent and the non-bifurcated stent each comprises a metal.

51. The system of claim 35, wherein the extension has a thickness of about 5 μ

m to about 50 μ

m.

52. The system of claim 35 wherein the first tubular portion, the second tubular portion and the third tubular portion are all integral with each other.

53. The system of claim 35 wherein the first tubular portion and the second tubular portion are integral with each other and the third tubular portion is connected to the first tubular portion.

54. A system for treating a bifurcated blood vessel comprising:

a bifurcated intravascular metal stent comprising a surface, a first tubular portion, a second tubular portion, a third tubular portion having an end and a tubular extension attached to the end of the third tubular portion;

wherein the extension comprises a first polymer and

a non-bifurcated intravascular metal stent comprising a surface, a first end and a second end, wherein the first end of the non-bifurcated stent forms an overlap with less than the entire extension; and

a graft comprising the first polymer disposed within the bifurcated stent.